scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1034236750 |
P356 | DOI | 10.1007/S00436-009-1656-X |
P698 | PubMed publication ID | 19851783 |
P2093 | author name string | Shu-Hua Xiao | |
Jing-Yan Mei | |||
Pei-Ying Jiao | |||
P2860 | cites work | Antimalarials. 7. Bis(trifluoromethyl)-.alpha.-(2-piperidyl)-4-quinolinemethanols | Q47958582 |
Susceptibility of Schistosoma japonicum to different developmental stages to praziquantel. | Q52255445 | ||
[Effect of praziquantel in vitro on different developmental stages of Schistosoma japonicum] | Q52264014 | ||
Light and electron microscopic studies on the effect of praziquantel on Schistosoma mansoni, Dicrocoelium dendriticum, and Fasciola hepatica (Trematoda) in vitro. | Q52506843 | ||
[Attachment of mouse neutrophils in vitro on the praziquantel-damaged surface of adult Schistosoma japonicum in the presence of immune sera] | Q54105046 | ||
The effects of immune rhesus monkey serum on schistosomula of Schistosoma mansoni during cultivation in vitro | Q69381737 | ||
[Prophylactic activity of praziquantel in animals infected with Schistosoma japonicum] | Q70008697 | ||
[Studies on the efficacy of artemether in experimental schistosomiasis (author's transl)] | Q70446743 | ||
In vivo and in vitro experiments on the effects of praziquantel on Schistosoma mansoni. A light and electron microscopic study | Q70663091 | ||
[Observation on tegument damage of Schistosoma japonicum and penetration of host leukocytes into the worm body caused by pyquiton] | Q71056605 | ||
Factors contributing to reinfection with schistosomiasis japonica after treatment in the lake region of China | Q72659338 | ||
Pigment Formation in Schistosoma mansoni Infections in the White Mouse * | Q72755178 | ||
A technique for the perfusion of laboratory animals for the recovery of schistosomes | Q79596624 | ||
Praziquantel: The enigmatic antiparasitic | Q80819033 | ||
Development of antischistosomal drugs in China, with particular consideration to praziquantel and the artemisinins | Q22061953 | ||
Mefloquine--an aminoalcohol with promising antischistosomal properties in mice | Q28474353 | ||
Effect of single-dose oral mefloquine on the morphology of adult Schistosoma japonicum in mice | Q33449456 | ||
Schistosoma mansoni: chemotherapy of infections of different ages | Q34165519 | ||
Artemether, an effective new agent for chemoprophylaxis against shistosomiasis in China: its in vivo effect on the biochemical metabolism of the Asian schistosome | Q34287092 | ||
Interpreting low praziquantel cure rates of Schistosoma mansoni infections in Senegal | Q34537724 | ||
In vitro and in vivo studies of the effect of artemether on Schistosoma mansoni | Q35349636 | ||
In vitro and in vivo activities of synthetic trioxolanes against major human schistosome species | Q35758795 | ||
Implementation of human schistosomiasis control: Challenges and prospects | Q36492748 | ||
Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy. | Q36671618 | ||
Artemisinins for schistosomiasis and beyond. | Q36747308 | ||
Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis | Q37315241 | ||
Praziquantel: its use in control of schistosomiasis in sub-Saharan Africa and current research needs. | Q37413446 | ||
Efficacy and side-effects of two praziquantel treatments against Schistosoma haematobium infection, among schoolchildren from Côte d'Ivoire | Q38452685 | ||
Reinfection with Schistosoma haematobium and mansoni despite repeated praziquantel office treatment in Niger, Mali | Q38498113 | ||
Evidence for an immune-dependent action of praziquantel on Schistosoma mansoni in mice | Q38975063 | ||
Further study on mefloquine concerning several aspects in experimental treatment of mice and hamsters infected with Schistosoma japonicum | Q43268214 | ||
Histopathological alteration of juvenile Schistosoma japonicum in mice following treatment with single-dose mefloquine | Q43276124 | ||
Artemether administered together with haemin damages schistosomes in vitro | Q43560771 | ||
Schistosoma japonicum: In vitro effects of artemether combined with haemin depend on cultivation media and appraisal of artemether products appearing in the media | Q44377255 | ||
Experimental studies on early treatment of schistosomal infection with artemether | Q44894719 | ||
Histopathological changes in adult Schistosoma japonicum harbored in mice treated with a single dose of mefloquine | Q46120029 | ||
[Impact of host factors on the schistosome-killing process induced by praziquantel]. | Q46152523 | ||
Schistosomicidal activity of the antimalarial drug, mefloquine, in Schistosoma mansoni-infected mice | Q46400668 | ||
Study progress on the mode of action of praziquantel against schistosomes | Q46622656 | ||
In vitro and in vivo effect of levopraziquantel, dextropraziquantel versus racemic praziquantel on different developmental stages of Schistosoma japonicum. | Q47907095 | ||
P433 | issue | 1 | |
P921 | main subject | praziquantel | Q424145 |
mefloquine | Q736270 | ||
Schistosoma japonicum | Q1256989 | ||
P304 | page(s) | 237-246 | |
P577 | publication date | 2009-10-23 | |
P1433 | published in | Parasitology Research | Q15755242 |
P1476 | title | The in vitro effect of mefloquine and praziquantel against juvenile and adult Schistosoma japonicum | |
P478 | volume | 106 |
Q28533754 | 3-oxoacyl-ACP reductase from Schistosoma japonicum: integrated in silico-in vitro strategy for discovering antischistosomal lead compounds |
Q35128551 | A Meta-Analysis of Experimental Studies of Attenuated Schistosoma mansoni Vaccines in the Mouse Model. |
Q27678492 | Aldose reductase from Schistosoma japonicum: crystallization and structure-based inhibitor screening for discovering antischistosomal lead compounds |
Q44243940 | Anthelminthic activity of the cyclotides (kalata B1 and B2) against schistosome parasites |
Q28535482 | Antioxidant, antibacterial and antischistosomal activities of extracts from Grateloupia livida (Harv). Yamada |
Q34071489 | Comparison of the in vitro Effects of One-day Exposure to Amodiaquine and Praziquantel on Schistosoma mansoni Adult Worm Pairs |
Q47956006 | Effect of mefloquine administered orally at single, multiple, or combined with artemether, artesunate, or praziquantel in treatment of mice infected with Schistosoma japonicum |
Q47872179 | Effect of ozonide OZ418 against Schistosoma japonicum harbored in mice |
Q34129038 | Effect of praziquantel on adult Echinostoma paraensei worms in experimentally infected mice |
Q51400781 | Effect of the in vivo activity of dihydroartemisinin against Schistosoma mansoni infection in mice. |
Q51456665 | Effects of artemether, artesunate and dihydroartemisinin administered orally at multiple doses or combination in treatment of mice infected with Schistosoma japonicum. |
Q36719660 | Efficacy and side effects of praziquantel in the treatment of Schistosomiasis mansoni in schoolchildren in Shesha Kekele Elementary School, Wondo Genet, Southern Ethiopia |
Q37787339 | From innovation to application: Social–ecological context, diagnostics, drugs and integrated control of schistosomiasis |
Q47988412 | Further studies on mefloquine and praziquantel alone or interaction of both drugs against Schistosoma japonicum in vitro |
Q43268214 | Further study on mefloquine concerning several aspects in experimental treatment of mice and hamsters infected with Schistosoma japonicum |
Q90004065 | Heat shock protein 70 (Hsp70) in Schistosoma mansoni and its role in decreased adult worm sensitivity to praziquantel |
Q47998282 | Histopathological changes of juvenile Schistosoma japonicum harbored in mice treated orally with mefloquine at a smaller single dose |
Q37699875 | In Vitro Assessment of Anthelmintic Activities of Rauwolfia vomitoria (Apocynaceae) Stem Bark and Roots against Parasitic Stages of Schistosoma mansoni and Cytotoxic Study |
Q31115153 | In vitro effects of amodiaquine on paired Schistosoma mansoni adult worms at concentrations of less than 5 µg/mL |
Q34341901 | In vitro praziquantel test capable of detecting reduced in vivo efficacy in Schistosoma mansoni human infections |
Q36750810 | In vitro tegumental alterations on adult Fasciola gigantica caused by mefloquine |
Q46299519 | In vivo schistosomicidal activity of three novels 8-hydroxyquinoline derivatives against adult and immature worms of Schistosoma mansoni. |
Q34366867 | Mefloquine, a new type of compound against schistosomes and other helminthes in experimental studies |
Q38495064 | Natural products with antischistosomal activity. |
Q36485623 | Oxadiazole-2-oxides may have other functional targets, in addition to SjTGR, through which they cause mortality in Schistosoma japonicum |
Q46921243 | Pharmacodynamics of mefloquine and praziquantel combination therapy in mice harbouring juvenile and adult Schistosoma mansoni |
Q34125799 | Research and development of antischistosomal drugs in the People's Republic of China a 60-year review |
Q41014621 | Significance of higher drug concentration in erythrocytes of mice infected with Schistosoma japonicum and treated orally with mefloquine at single doses |
Q38050973 | Susceptibility or resistance of praziquantel in human schistosomiasis: a review |
Q39607879 | Synthesis of fluorescent derivatives of praziquantel: cell-imaging and interaction with Schistosoma japonicum cercariae |
Q56362996 | The Impact of Artesunate-Amodiaquine on Schistosoma mansoni Infection among Children Infected by Plasmodium in Rural Area of Lemfu, Kongo Central, Democratic Republic of the Congo |
Q28481160 | Thioredoxin glutathione reductase as a novel drug target: evidence from Schistosoma japonicum |
Q36442593 | Transcriptional analysis of Schistosoma mansoni treated with praziquantel in vitro |
Q28489110 | Transcriptional responses of in vivo praziquantel exposure in schistosomes identifies a functional role for calcium signalling pathway member CamKII |
Q39004186 | What is the mechanism of action of praziquantel and how might resistance strike? |
Search more.